发明名称 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-(2-(4- fluorophenyl) ethyl)-4- piperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907
摘要 Esters of (2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol (MDL 100907) (I), are new. Esters of (+)-alpha-(2,3-dimethoxy- phenyl)-1-[2(4-fluorophenyl)ethyl]-4-piperidine methanol of formula (I) and their stereoisomers and salts are new. [Image] R : 4-20C alkyl. ACTIVITY : Neuroleptic; Antimanic; Antidepressant; Tranquilizer; Antiaddictive; Cardiant; Antianginal; Thrombolytic; Eating-Disorders-Gen.; Vasotropic; Antiarrhythmic; Sedative. (+)-alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl(ethyl]-4- piperidine methanol decanoate (120 mg/kg equivalent to MDL-100907) was administered to (+/-)-DOI HCl injected male Sprague-Dawley rats. (+/-)-DOI HCl induces several quantifiable behaviours in rats. Significantly antagonized DOI-induced behavior in the rats was observed for a full 28 days. The effect was no longer significant at day 40. MECHANISM OF ACTION : Antiserotonin-2A.
申请公布号 AU1083099(A) 申请公布日期 2000.05.01
申请号 AU19990010830 申请日期 1998.10.14
申请人 AVENTIS PHARMACEUTICALS INC. 发明人 ALBERT A. CARR;LUC E. VAN HIJFTE;RAYMOND W. KOSLEY
分类号 C07D211/48;A61K;A61K31/445;A61P7/02;A61P9/06;A61P9/10;A61P25/00;A61P25/18;A61P25/22;A61P25/24;A61P25/30;C07D;C07D211/22 主分类号 C07D211/48
代理机构 代理人
主权项
地址